. . . . . . . . . . . "a(CHEBI:ceramide) -| r(HGNC:PPARG)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "The addition of exogenous N-acetylsphingosine (C2-ceramide) or increasing endogenous ceramide levels inhibited the expression of C/EBPalpha and PPARgamma, and blocked adipocyte development." . . "Selventa" . . . . "2014-07-03T14:30:03.901+02:00"^^ . . .